Cardiorenal benefits of SGLT2i versus DPP4i in type 2 diabetes without cardiovascular and renal diseases. Qiu M, Zhou X, Zhang M. Diabetes Obes Metab 2021 Nov 2. doi: 10.1111/dom.14588.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qiu M, Zhou X, Zhang M. Cardiorenal benefits of SGLT2i versus DPP4i in type 2 diabetes without cardiovascular and renal diseases. Diabetes Obes Metab 2021 Nov 2. doi: 10.1111/dom.14588.
PMID: 34729884